BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7946273)

  • 1. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
    Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
    APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
    Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
    APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.
    Kosmehl H; Berndt A; Strassburger S; Borsi L; Rousselle P; Mandel U; Hyckel P; Zardi L; Katenkamp D
    Br J Cancer; 1999 Nov; 81(6):1071-9. PubMed ID: 10576667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of fibronectin isoforms in human renal disease.
    Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
    J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.
    Midulla M; Verma R; Pignatelli M; Ritter MA; Courtenay-Luck NS; George AJ
    Cancer Res; 2000 Jan; 60(1):164-9. PubMed ID: 10646869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts.
    Pujuguet P; Hammann A; Moutet M; Samuel JL; Martin F; Martin M
    Am J Pathol; 1996 Feb; 148(2):579-92. PubMed ID: 8579120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
    Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: potential consequences for clinical management.
    Cruz IB; Meijer CJ; Snijders PJ; Snow GB; Walboomers JM; van Der Waal I
    J Pathol; 2000 Jun; 191(2):132-7. PubMed ID: 10861571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies in the diagnosis of epithelial premalignant lesions.
    Dabelsteen E; Graem N; Hakomori S; Young WW
    Bull Cancer; 1983; 70(2):127-31. PubMed ID: 6871487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors.
    Oyama F; Hirohashi S; Sakamoto M; Titani K; Sekiguchi K
    Cancer Res; 1993 May; 53(9):2005-11. PubMed ID: 8481903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
    Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
    Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
    Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
    Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
    Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L
    Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease.
    Halliday NL; Rayan GM; Zardi L; Tomasek JJ
    J Hand Surg Am; 1994 May; 19(3):428-34. PubMed ID: 8056970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues.
    Borsi L; Balza E; Allemanni G; Zardi L
    Exp Cell Res; 1992 Mar; 199(1):98-105. PubMed ID: 1310473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of alpha(v)beta6 integrin in oral leukoplakia.
    Hamidi S; Salo T; Kainulainen T; Epstein J; Lerner K; Larjava H
    Br J Cancer; 2000 Apr; 82(8):1433-40. PubMed ID: 10780523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesis.
    Vogel W; Berndt A; Müller A; Dahse R; Haas KM; Borsi L; Zardi L; Kosmehl H
    Int J Mol Med; 2003 Dec; 12(6):831-7. PubMed ID: 14612953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate changes in squamous cell carcinomas.
    Dabelsteen E; Clausen H; Mandel U
    APMIS Suppl; 1992; 27():130-8. PubMed ID: 1520522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Several non-traumatic examination methods for oral leukoplakia lichen planus and carcinoma].
    Pang JF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1990 Sep; 25(5):282-4, 318. PubMed ID: 2128251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.